Literature DB >> 6947403

Decreased antibody-dependent cellular cytotoxicity in various types of leukaemia in man.

M Jakóbisiak, A Janowska-Wieczorek, H Dobaczewska, M Kańtoch, M Marczak, P Oblakowski, W Lasek, M Sosnowska.   

Abstract

Antibody-dependent cellular cytotoxicity (ADCC) by cells from peripheral blood was studied in patients with; chronic lymphocytic leukaemia (CLL), chronic granulocytic leukaemia (CGL), acute lymphoblastic leukaemia (ALL), acute non-lymphoid leukaemia (ANLL) and compared with that of healthy donors. The ADCC activity in all the types of leukaemia was on the average lower as compared with the control values, being especially low in both CLL and CGL. Further, it has also been shown that the ADCC activity of non-leukaemic blood cells in ANLL was lower as compared with control values. The latter observation indicates that, at least in ANLL, the reduced ADCC potential of peripheral blood cells is not due to dilution of effector cells by poorly- or non-active leukaemic cells.

Entities:  

Mesh:

Year:  1981        PMID: 6947403     DOI: 10.1111/j.1600-0609.1981.tb00470.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  3 in total

1.  Studies on the lymphocytic subpopulations in acute non-lymphocytic leukemia.

Authors:  M X Zhou; L Y Wang; G X Shen; G Z Liu
Journal:  Acta Acad Med Wuhan       Date:  1984

2.  Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity.

Authors:  Ricardo García-Muñoz; Ascensión López-Díaz-de-Cerio; Jesus Feliu; Angel Panizo; Pilar Giraldo; Mercedes Rodríguez-Calvillo; Carlos Grande; Esther Pena; Mayte Olave; Carlos Panizo; Susana Inogés
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

3.  Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells.

Authors:  Rosa Lapalombella; Bo Yu; Georgia Triantafillou; Qing Liu; Jonathan P Butchar; Gerard Lozanski; Asha Ramanunni; Lisa L Smith; William Blum; Leslie Andritsos; Da-Sheng Wang; Amy Lehman; Ching-Shih Chen; Amy J Johnson; Guido Marcucci; Robert J Lee; L James Lee; Susheela Tridandapani; Natarajan Muthusamy; John C Byrd
Journal:  Blood       Date:  2008-09-04       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.